Edition:
United Kingdom

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

6.70USD
8:55pm GMT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.70
Open
$6.70
Day's High
$6.82
Day's Low
$6.64
Volume
20,058
Avg. Vol
47,079
52-wk High
$13.84
52-wk Low
$5.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.41 -0.468
Jun '18 0.38 -0.427
Mar '18 0.37 -0.477
FY 2017 Dec '17 0.00 -0.581
Sep '17 0.00 -0.526
Jun '17 0.00 -0.523
Mar '17 1.10 -0.492
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 0.30 0.40 0.00 --
Quarter Ending Jun-19 4 0.30 0.40 0.00 --
Year Ending Dec-19 7 1.60 2.50 0.00 32.76
Earnings (per share)
Quarter Ending Mar-19 4 -0.47 -0.44 -0.49 --
Quarter Ending Jun-19 4 -0.48 -0.45 -0.51 --
Year Ending Dec-19 7 -2.04 -1.80 -2.58 -2.84
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) 296.49 4.12 6.28
Price to Book (MRQ) 4.61 5.11 5.27
Price to Tangible Book (MRQ) 4.62 5.85 6.79
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 71.22 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 4.14 5.87
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 14.10 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago 11.27 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.26
Current Ratio (MRQ) 13.28 2.98 3.08
LT Debt to Equity (MRQ) 0.01 8.86 11.38
Total Debt to Equity (MRQ) 0.15 12.90 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.65 53.78
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -3,454.79 -- --
EBITD - 5 Yr. Avg -- 17.95 12.87
Operating Margin (TTM) -3,553.46 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.31
Pre-Tax Margin (TTM) -3,527.29 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.61
Net Profit Margin (TTM) -3,527.29 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.88
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,782 959,798,954 844,239,694
Net Income/Employee (TTM) -909,400 113,819,313 100,064,161
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.02 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -62.53 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -68.14 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -442.37 16.31 15.99
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % 0.00 -- --
EPS (TTM) % -165.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syros Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -6.81 -10.02 53 22
13 Week -9.09 -13.51 94 39
26 Week 8.91 0.63 99 33
52 Week 12.35 -4.77 99 9
YTD 31.66 15.63 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.90%
# of Holders: 104
Total Shares Held: 25,545,505
3 Mo. Net Change: 15,499
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 7
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.